Seres Therapeutics is a late-clinical stage biotechnology company working to shift the treatment paradigm for a wide range of diseases by uncovering and enhancing the function of the human microbiome. Learn more: https://www.serestherapeutics.com/
Location: United States, Massachusetts, Cambridge
Member count: 201-500
Founded date: 2010
Investors 2
Date | Name | Website |
- | RA Capital... | racap.com |
- | Sofinnova ... | sofinnova.... |
Mentions in press and media 11
Date | Title | Description | Category | Author | Source |
30.11.2022 | FDA approv... | The Food and Drug Administrati... | - | - | statnews.c... |
10.11.2021 | Bacthera a... | Press Release | Nov 10. 2021 0... | - | - | marketscre... |
19.06.2018 | 15 Boston ... | “Bacteria, it’s the only cultu... | Stories S... | - | bizjournal... |
12.06.2017 | Seres init... | Seres has long been a leader i... | - | - | medcitynew... |
12.06.2017 | Seres grab... | → Seres $MCRB is taking anot... | - | Emma Yasin... | endpts.com... |
12.06.2017 | Seres grab... | Seres $MCRB is taking anoth... | - | John Carro... | endpts.com... |
30.11.2016 | Axial Biot... | This builds on an array of pre... | - | - | medcitynew... |
08.08.2016 | How biotec... | A biotech company called Seres... | - | - | statnews.c... |
29.06.2016 | The biotec... | There was a time after the 20... | Financing | John Carro... | endpts.com... |
- | Seres init... | Microbiome therapies are now o... | - | - | medcitynew... |
Show more